The intervention trial of the effect of the double induction therapy with basiliximab and rituximab on the production of donor specific antibody after kidney transprantation.
Phase 2
Recruiting
- Conditions
- Chronic kidney disease
- Registration Number
- JPRN-UMIN000018625
- Lead Sponsor
- Fujita Health University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patient with a history of hypersensitivity to rituximab. Patient whom doctor has determined that there is not appropriate participation in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Production of donor specific antibody at two years after kidney transplantation.
- Secondary Outcome Measures
Name Time Method Serum creatinine,eGFR,an incidence of infection,rejection and adverse events at two years after kidney transplantation.